Aptus Pharma Ltd

Aptus Pharma Ltd

₹ 83.6 -1.46%
01 Oct - close price
About

Incorporated in 2010, Aptus Pharma Ltd is engaged in the business of marketing and distribution of finished pharmaceutical formulations.[1]

Key Points

Business Profile[1]
Aptus Pharma Limited is a Gujarat-based marketer and distributor of pharmaceutical formulations, operating in an asset-light model through contract manufacturing partners. It offers a diverse portfolio of 194 products across multiple therapeutic categories.

  • Market Cap 57.4 Cr.
  • Current Price 83.6
  • High / Low 84.8 / 80.8
  • Stock P/E 18.5
  • Book Value
  • Dividend Yield 0.00 %
  • ROCE 38.2 %
  • ROE 70.9 %
  • Face Value 10.0

Pros

  • Company's working capital requirements have reduced from 51.8 days to 36.4 days

Cons

  • Company might be capitalizing the interest cost

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Part of BSE SME IPO

Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Operating Profit
OPM %
Interest
Depreciation
Profit before tax
Tax %
EPS in Rs
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2023 Mar 2024 Mar 2025
13.90 17.81 24.56
13.28 16.27 19.71
Operating Profit 0.62 1.54 4.85
OPM % 4.46% 8.65% 19.75%
0.00 0.03 0.08
Interest 0.14 0.24 0.47
Depreciation 0.18 0.21 0.27
Profit before tax 0.30 1.12 4.19
Tax % 33.33% 28.57% 26.01%
0.19 0.80 3.10
EPS in Rs 6.33 26.67 6.20
Dividend Payout % 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 38%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 288%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 71%

Balance Sheet

Figures in Rs. Crores

Mar 2023 Mar 2024 Mar 2025
Equity Capital 0.30 0.30 5.00
Reserves 0.67 1.47 1.97
2.22 5.31 10.35
3.02 2.95 4.60
Total Liabilities 6.21 10.03 21.92
0.52 0.63 0.99
CWIP 0.00 0.00 0.00
Investments 0.00 0.00 0.00
5.69 9.40 20.93
Total Assets 6.21 10.03 21.92

Cash Flows

Figures in Rs. Crores

Mar 2023 Mar 2024 Mar 2025
-0.18 -2.17 -1.84
-0.35 -0.30 -0.54
0.81 2.86 6.68
Net Cash Flow 0.28 0.38 4.30

Ratios

Figures in Rs. Crores

Mar 2023 Mar 2024 Mar 2025
Debtor Days 63.02 68.66 83.82
Inventory Days 176.00 183.57 285.06
Days Payable 104.07 72.25 52.89
Cash Conversion Cycle 134.95 179.97 315.98
Working Capital Days 51.99 67.02 36.41
ROCE % 26.48% 38.20%

Shareholding Pattern

Numbers in percentages

3 Recently
Sep 2025
72.89%
10.03%
2.80%
14.29%
No. of Shareholders 213

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents